[{"Assets_0_Q2_USD":2150318000.0,"CommonStockSharesOutstanding_0_Q2_shares":784439632.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-218076000.0,"NetIncomeLoss_1_Q2_USD":-85570000.0,"NetIncomeLoss_2_Q2_USD":-253210000.0,"StockholdersEquity_0_Q2_USD":1553877000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]